Literature DB >> 20012647

Clinical practice: Diagnosis and management of Henoch-Schönlein purpura.

Hugh J McCarthy1, E Jane Tizard.   

Abstract

Henoch-Schönlein purpura (HSP) is the most common vasculitis of childhood. In this review, the main clinical features and complications are described. Although most features are self-limiting, renal disease is the most likely to result in long-term morbidity. Treatment of HSP nephritis is controversial, and the evidence for both prevention and treatment of established disease is reviewed. Follow-up for children presenting with HSP should be for at least 6 months and should include regular urine testing for proteinuria and haematuria and a blood pressure measurement. Women with a history of HSP during childhood are at increased risk of complications (such as proteinuria and hypertension) during pregnancy and should be monitored closely. This paper describes current practice with regard to investigation and management and proposes a practical care pathway of the management of a child with HSP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20012647     DOI: 10.1007/s00431-009-1101-2

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  39 in total

Review 1.  Intravenous immunoglobulin therapy for severe digestive manifestations of Henoch-Schönlein purpura.

Authors:  T Lamireau; L Rebouissoux; J P Hehunstre
Journal:  Acta Paediatr       Date:  2001-09       Impact factor: 2.299

2.  Henoch-Schönlein purpura in children from northwestern Spain: a 20-year epidemiologic and clinical study.

Authors:  M C Calviño; J Llorca; C García-Porrúa; J L Fernández-Iglesias; P Rodriguez-Ledo; M A González-Gay
Journal:  Medicine (Baltimore)       Date:  2001-09       Impact factor: 1.889

Review 3.  Henoch Schonlein purpura.

Authors:  E J Tizard; M J J Hamilton-Ayres
Journal:  Arch Dis Child Educ Pract Ed       Date:  2008-02       Impact factor: 1.309

4.  Steroid effects on the course of abdominal pain in children with Henoch-Schonlein purpura.

Authors:  N D Rosenblum; H S Winter
Journal:  Pediatrics       Date:  1987-06       Impact factor: 7.124

Review 5.  Henoch-Schönlein purpura in children. Report of 100 patients and review of the literature.

Authors:  F T Saulsbury
Journal:  Medicine (Baltimore)       Date:  1999-11       Impact factor: 1.889

6.  Renal manifestations in Henoch-Schönlein purpura: a 10-year clinical study.

Authors:  Wen-Liang Chang; Yao-Hsu Yang; Li-Chieh Wang; Yu-Tsan Lin; Bor-Luen Chiang
Journal:  Pediatr Nephrol       Date:  2005-06-10       Impact factor: 3.714

7.  Gastrointestinal manifestations in Henoch-Schönlein purpura: a review of 261 patients.

Authors:  W-L Chang; Y-H Yang; Y-T Lin; B-L Chiang
Journal:  Acta Paediatr       Date:  2004-11       Impact factor: 2.299

8.  Henoch-Schönlein purpura nephritis: course of disease and efficacy of cyclophosphamide.

Authors:  Penina Tarshish; Jay Bernstein; Chester M Edelmann
Journal:  Pediatr Nephrol       Date:  2003-11-22       Impact factor: 3.714

9.  IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria.

Authors:  Rosanna Coppo; Licia Peruzzi; Alessandro Amore; Antonio Piccoli; Pierre Cochat; Rosario Stone; Martin Kirschstein; Tommy Linné
Journal:  J Am Soc Nephrol       Date:  2007-05-18       Impact factor: 10.121

10.  A randomized, placebo-controlled trial of prednisone in early Henoch Schönlein Purpura [ISRCTN85109383].

Authors:  Adam M Huber; Jim King; Peter McLaine; Terry Klassen; Mary Pothos
Journal:  BMC Med       Date:  2004-04-02       Impact factor: 8.775

View more
  29 in total

1.  Henoch-Schönlein purpura with hypocomplementemia.

Authors:  Qiang Lin; Yue Min; Yanhong Li; Yun Zhu; Xiaoxiang Song; Qinying Xu; Lifeng Wang; Jiang Cheng; Qihua Feng; Xiaozhong Li
Journal:  Pediatr Nephrol       Date:  2012-01-21       Impact factor: 3.714

2.  Point-of-care ultrasound identification of pneumatosis intestinalis associated with Henoch-Schönlein purpura gastrointestinal involvement: A case report.

Authors:  Sek Wan Tan; Vigil James; Aswin Warier; Gene Yong-Kwang Ong
Journal:  World J Emerg Med       Date:  2021

Review 3.  Acute hemorrhagic edema of young children: a concise narrative review.

Authors:  Elisabetta Fiore; Mattia Rizzi; Giacomo D Simonetti; Luca Garzoni; Mario G Bianchetti; Alberto Bettinelli
Journal:  Eur J Pediatr       Date:  2011-06-15       Impact factor: 3.183

4.  Crescent lesions are not a predictive factor in adult-onset Henoch-Schönlein purpura nephritis.

Authors:  Zheng-Xia Zhong; Jia-Xing Tan; Yi Tang; Li Tan; Gai-Qin Pei; Wei Qin
Journal:  Clin Exp Med       Date:  2019-07-10       Impact factor: 3.984

Review 5.  [Clinical features and therapy of rheumatic diseases and vasculitides in childhood].

Authors:  K Tenbrock
Journal:  Hautarzt       Date:  2014-09       Impact factor: 0.751

6.  Predictors of hospital length of stay in pediatric Henoch-Schönlein purpura.

Authors:  Neta Cohen; Francis B Mimouni; Nadav Friedel; Gil Amarilyo
Journal:  Rheumatol Int       Date:  2015-03-25       Impact factor: 2.631

7.  Studying cytokines of T helper cells in the kidney disease of IgA vasculitis (Henoch-Schönlein purpura).

Authors:  Bora Gülhan; Diclehan Orhan; Gülsev Kale; Nesrin Besbas; Seza Özen
Journal:  Pediatr Nephrol       Date:  2015-02-04       Impact factor: 3.714

8.  Henoch-Schonlein purpura with intestinal perforation and cerebral hemorrhage: a case report.

Authors:  Hong-Liang Wang; Hai-Tao Liu; Qi Chen; Yang Gao; Kai-Jiang Yu
Journal:  World J Gastroenterol       Date:  2013-04-28       Impact factor: 5.742

Review 9.  Urological Manifestations of Henoch-Schonlein Purpura: A Review.

Authors:  Amanda Dalpiaz; Richard Schwamb; Yimei Miao; Jacquelyn Gonka; Wayne Walzter; Sardar A Khan
Journal:  Curr Urol       Date:  2015-07-10

10.  Cerebral Vasculitis in Henoch-Schönlein Purpura: A Case Report.

Authors:  Meltem Akçaboy; Kibriya Fidan; Yaşar Kandur; Emel Isiyel; Bahar Büyükkaragöz; Sevcan Azime Bakkaloğlu Ezgü; Necla Buyan; Enver Hasanoğlu; Oğuz Söylemezoğlu
Journal:  Arch Rheumatol       Date:  2017-03-24       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.